Similar Items: A randomised controlled trial of N-acetylcysteine in the management of anti-tuberculosis drug-induced liver injury
- Development of 3D multicellular liver organoids derived from human induced pluripotent stem cells to model antiretroviral therapy induced liver injury
- N-Acetylcysteine for non-paracetamol drug-induced liver injury: A systemic review
- The fumonisin B₁-fed rat as a model for liver injury, oval ('progenitor') cell proliferation, and carcinogenesis
- Hepatocyte proliferation and DNA synthesis after partial orthotopic liver transplantation
- Taurine and protocatechuic acid attenuate Vincristine sulphate‑induced bone marrow, liver and intestinal injuries via anti‑oxidative, anti‑inflammatory and anti‑apoptotic activities
- Lignocaine extraction ratio and clearance as an indicator of hypoxic hepatic injury : a study using the in situ and the isolated perfused pig liver
Author: Cohen, Karen
- A randomised controlled trial of N-acetylcysteine in the management of anti-tuberculosis drug-induced liver injury
- Morbidity from antiretroviral metabolic effects in Africa: The Mama Study
- Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
- The burden of serious adverse drug reactions in South Africa
- Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis
- N-Acetylcysteine for non-paracetamol drug-induced liver injury: A systemic review